The Patent Finder
US

Construction of Chimeric Antigen Receptor Targeting CD20 Antigen and Activity Identification of Engineered T Cells Thereof

US 11,618,778 In force
OverviewFamilyAssignmentsSources & methods

Term ends Feb 8, 2038 · High confidence

Filed Apr 19, 2022 as application 17/723,859 · Granted Apr 4, 2023
Base term, 20 years from filing
Today
20 years from filing
2018 2038
Clock starts
Feb 8, 2018
Term ends
Feb 8, 2038
Granted
Apr 4, 2023
base term fee events Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
9
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. 1 of 3 maintenance fees is paid so far. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Feb 8, 2018, when application PCT/CN2018/075867, the earliest non-provisional in its chain, was filed (this one was filed Apr 19, 2022)Feb 8, 2038High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events1 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderFeb 8, 2038High confidence

This family

US 11,066,457In force
Feb 2038
Feb 2038
US 11,472,858In force
Feb 2038
Feb 2038
US 11,618,778this patent
Feb 2038
Feb 2038
US 11,608,369In force
Feb 2038
Feb 2038
US 12,583,903In force
Feb 2038
Feb 2038
US 12,747,279In force
Feb 2038
Feb 2038
Application 18/263,050Pending
not computed
not computed
7 of 9 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Apr 19, 2022
Reel 59637, frame 1
Yao, Yihong; Huang, Jiaqi; Zhu, Shigui; Zhu, Wei; Yao, Xin; Li, Zhiyuan; Zhang, Li; Zhu, Lin; Ma, Anyun; Wei, Yutian; Li, Yanfeng; Wang, Qingxia; He, JiapingCellular Biomedicine Group (Shanghai) Ltd.; Cellular Biomedicine Group (Wuxi) Ltd.Assignment of Assignor's Interest
Apr 19, 2022
Reel 59637, frame 335
Cellular Biomedicine Group (Shanghai) Ltd.Cellular Biomedicine Group HK LimitedAssignment of Assignor's Interest
Apr 19, 2022
Reel 59637, frame 469
Cellular Biomedicine Group (Wuxi) Ltd.Cellular Biomedicine Group HK LimitedAssignment of Assignor's Interest
Apr 19, 2022
reel/frame not recorded
He, Jiaping; Huang, Jiaqi; Li, Yanfeng; Li, Zhiyuan; Ma, Anyun; Wang, Qingxia; Wei, Yutian; Yao, Xin; Yao, Yihong; Zhang, Li; Zhu, Lin; Zhu, Shigui; Zhu, WeiCellular Biomedicine Group (Shanghai) Ltd.Assignment of Assignor's Interest
Apr 19, 2022
reel/frame not recorded
He, Jiaping; Huang, Jiaqi; Li, Yanfeng; Li, Zhiyuan; Ma, Anyun; Wang, Qingxia; Wei, Yutian; Yao, Xin; Yao, Yihong; Zhang, Li; Zhu, Lin; Zhu, Shigui; Zhu, WeiCellular Biomedicine Group (Wuxi) Ltd.Assignment of Assignor's Interest
Dec 15, 2022
Reel 62105, frame 405
Cellular Biomedicine Group HK Ltd.Cellular Biomedicine Group Inc.Assignment of Assignor's Interest
Jan 19, 2024
Reel 66356, frame 108
Cellular Biomedicine Group, Inc.Abelzeta Inc.Change of Name

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited